SIRI vs. ABBV

Last updated Apr 2, 2026

Compare and contrast key facts about Sirius XM Holdings Inc. (SIRI) and AbbVie Inc. (ABBV).

Performance

SIRI vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sirius XM Holdings Inc. (SIRI) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

SIRI vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SIRI Sirius XM Holdings Inc.	18.58%	-7.97%	-56.93%	-4.27%	-3.21%	0.74%	-10.11%	26.24%	7.28%	21.42%
ABBV AbbVie Inc.	-5.16%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%

Fundamentals

Market Cap SIRI : $8.33B ABBV : $381.37B
EPS SIRI : $2.26 ABBV : $2.38
PE Ratio SIRI : 10.36 ABBV : 90.18
PS Ratio SIRI : 0.97 ABBV : 6.23
Total Revenue (TTM) SIRI : $8.56B ABBV : $61.16B
Gross Profit (TTM) SIRI : $4.23B ABBV : $44.85B
EBITDA (TTM) SIRI : $1.80B ABBV : $28.29B

Returns By Period

In the year-to-date period, SIRI achieves a 18.58% return, which is significantly higher than ABBV's -5.16% return. Over the past 10 years, SIRI has underperformed ABBV with an annualized return of -3.09%, while ABBV has yielded a comparatively higher 18.93% annualized return.

SIRI

• 1D: 1.43%
• 1M: 6.70%
• YTD: 18.58%
• 6M: 5.94%
• 1Y: 12.12%
• 3Y*: -12.99%
• 5Y*: -14.96%
• 10Y*: -3.09%

ABBV

• 1D: -1.15%
• 1M: -8.23%
• YTD: -5.16%
• 6M: -10.68%
• 1Y: 7.72%
• 3Y*: 14.56%
• 5Y*: 19.12%
• 10Y*: 18.93%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SIRI vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SIRI

SIRI Risk / Return Rank: 50
SIRI Sharpe Ratio Rank: 52
SIRI Sortino Ratio Rank: 47
SIRI Omega Ratio Rank: 46
SIRI Calmar Ratio Rank: 54
SIRI Martin Ratio Rank: 52

ABBV

ABBV Risk / Return Rank: 47
ABBV Sharpe Ratio Rank: 51
ABBV Sortino Ratio Rank: 43
ABBV Omega Ratio Rank: 43
ABBV Calmar Ratio Rank: 50
ABBV Martin Ratio Rank: 50

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SIRI vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sirius XM Holdings Inc. (SIRI) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SIRI	ABBV	Difference
Sharpe ratio Return per unit of total volatility	0.32	0.29	+0.04
Sortino ratio Return per unit of downside risk	0.72	0.56	+0.16
Omega ratio Gain probability vs. loss probability	1.09	1.08	+0.01
Calmar ratio Return relative to maximum drawdown	0.53	0.36	+0.17
Martin ratio Return relative to average drawdown	1.02	0.80	+0.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SIRI vs. ABBV - Sharpe Ratio Comparison

The current SIRI Sharpe Ratio is 0.32, which is comparable to the ABBV Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of SIRI and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SIRI	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.32	0.29	+0.04
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.34	0.85	-1.19
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.08	0.74	-0.82
Sharpe Ratio (All Time) Calculated using the full available price history	-0.02	0.74	-0.75

Correlation

The correlation between SIRI and ABBV is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SIRI vs. ABBV - Dividend Comparison

SIRI's dividend yield for the trailing twelve months is around 4.61%, more than ABBV's 3.09% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SIRI Sirius XM Holdings Inc.	4.61%	5.40%	4.68%	1.81%	5.82%	1.04%	0.86%	0.69%	0.79%	0.76%	0.22%	0.00%
ABBV AbbVie Inc.	3.09%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%

Drawdowns

SIRI vs. ABBV - Drawdown Comparison

The maximum SIRI drawdown since its inception was -99.92%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for SIRI and ABBV.

Drawdown Indicators

	SIRI	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-99.92%	-45.09%	-54.83%
Max Drawdown (1Y) Largest decline over 1 year	-17.44%	-16.31%	-1.13%
Max Drawdown (5Y) Largest decline over 5 years	-73.87%	-21.92%	-51.95%
Max Drawdown (10Y) Largest decline over 10 years	-73.87%	-45.09%	-28.78%
Current Drawdown Current decline from peak	-95.57%	-10.68%	-84.89%
Average Drawdown Average peak-to-trough decline	-80.46%	-10.70%	-69.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.05%	7.58%	+1.47%

Volatility

SIRI vs. ABBV - Volatility Comparison

The current volatility for Sirius XM Holdings Inc. (SIRI) is 6.91%, while AbbVie Inc. (ABBV) has a volatility of 7.61%. This indicates that SIRI experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SIRI	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.91%	7.61%	-0.70%
Volatility (6M) Calculated over the trailing 6-month period	24.44%	18.69%	+5.75%
Volatility (1Y) Calculated over the trailing 1-year period	37.75%	27.07%	+10.68%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	44.65%	22.62%	+22.03%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.35%	25.70%	+11.65%

Financials

SIRI vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Sirius XM Holdings Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SIRI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Sirius XM Holdings Inc. reported a gross profit of 1.25B and revenue of 2.19B. Therefore, the gross margin over that period was 57.1%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.

SIRI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Sirius XM Holdings Inc. reported an operating income of 226.00M and revenue of 2.19B, resulting in an operating margin of 10.3%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.

SIRI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Sirius XM Holdings Inc. reported a net income of 99.00M and revenue of 2.19B, resulting in a net margin of 4.5%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.